Glenmark Pharmaceuticals informs about press release

23 Oct 2025 Evaluate
Glenmark Pharmaceuticals has informed that it enclosed a press release titled ‘Glenmark Pharmaceuticals Inc., USA to launch Ropivacaine Hydrochloride Injection USP, 40mg/20 mL (2 mg/mL), 150mg/30mL (5 mg/mL), and 200mg/20 mL (10 mg/mL) Single-Dose Vials’.

The above information is a part of company’s filings submitted to BSE. 

Glenmark Pharma Share Price

1996.55 -37.65 (-1.85%)
13-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1698.10
Dr. Reddys Lab 1267.60
Cipla 1330.85
Zydus Lifesciences 904.85
Lupin 2199.20
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×